AML (Acute Myelogenous Leukemia)

VEN+IDAC vs IDAC in AML

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials

A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies

Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation

Combination of HMA and Venetoclax With Posaconazole in Patients With Acute Myeloid Leukemia: A Study of Plasma Concentrations

Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission.

The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia

The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT

Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia

Use of Venetoclax , AML , Sohag , Egypt

The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors

Gut Health in Children With Cancer

Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade

CD123-CD16-NK Cells Immunotherapy for AML

Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT

Efficacy of Venetoclax Combined with Intensive Chemotherapy in Different Subgroups of AML

Preventing Stem Cell Transplant Complications With a Blood Separator Machine

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

Stem Cell Transplantation for Patients With Cancers of the Blood